效应器
免疫系统
癌症研究
肿瘤微环境
多路复用
生物
体外
细胞毒性T细胞
细胞
医学
头颈部鳞状细胞癌
免疫学
化疗
免疫组织化学
生物标志物
癌细胞
NK-92
癌症
先天免疫系统
抗体
功能(生物学)
T细胞
免疫检查点
免疫疗法
作者
Guo Li,Wenhao Xiao,Haijun Wu,Chao Liu,Liang Gong,Wei He,Zhuo Shao,Jing Bai,Xuefeng Xia,Xin Yi,Yunyun Wang,Shanhong Lu,Li She,Juncheng Wang,Gangcai Zhu,Xiaojuan Zhou,Wenmei Wang,Liangfang Shen,Nu Zhang,X. Wang
标识
DOI:10.1038/s41467-026-68676-x
摘要
Hypopharyngeal squamous cell carcinoma (HPSCC), an aggressive head and neck cancer with dismal prognosis, faces persistent chemoresistance to standard TPF (docetaxel, cisplatin, 5-fluorouracil) regimen. However, the immunological mechanisms underlying chemoresistance remain undefined. Here, we perform longitudinal single-cell RNA sequencing (scRNA-seq) profiling of paired pre-/post-TPF HPSCC specimens, mapping immune cell dynamics underlying chemoresistance. Our study identifies ZNF683+ natural killer (NK) cells as a gatekeeper of chemotherapy efficacy through integrated single-cell transcriptomics, spatial multiplex immunohistochemistry and functional validation. Moreover, pretreatment baseline enrichment of ZNF683+ NK cells predicts TPF response, while GZMK+CD8+ effector memory T cells function as the predominant immunologic effector to successful TPF intervention. Mechanistically, bioinformatics and in vitro coculture data reveal that ZNF683+ NK cells directly interact with CD8+ T cells, and drive an MHC-I-dependent licensing of polyfunctional GZMK+CD8+ effector memory T cells. Collectively, this NK-CD8+ axis provides a potential predictive biomarker and therapeutic target to overcome chemoresistance in patients with HPSCC. In patients with hypopharyngeal squamous cell carcinoma (HPSCC), resistance to the standard-of-care induction chemotherapy often occurs. Here, using longitudinal single-cell transcriptomic profiling of HPSCC samples from patients receiving induction chemotherapy, the authors identify a ZNF683-high natural killer (NK) cell population as a predictor of chemotherapy response.
科研通智能强力驱动
Strongly Powered by AbleSci AI